Suppr超能文献

调查 1 型和 2 型糖尿病患者的低血糖信心。

Investigating Hypoglycemic Confidence in Type 1 and Type 2 Diabetes.

机构信息

1 Department of Psychiatry, University of California , San Diego, and Behavioral Diabetes Institute, San Diego, California.

2 Department of Family and Community Medicine, University of California , San Francisco, San Francisco, California.

出版信息

Diabetes Technol Ther. 2017 Feb;19(2):131-136. doi: 10.1089/dia.2016.0366. Epub 2016 Dec 20.

Abstract

BACKGROUND

While research designed to understand the concerns about hypoglycemia among patients with diabetes has been primarily focused on the investigation of fear and anxiety, recent evidence suggests a potentially important and conceptually distinct element-hypoglycemic confidence. To investigate this dimension, we developed the Hypoglycemic Confidence Scale (HCS); herein, we describe the construction and validation of the HCS and examine how key patient factors are associated with hypoglycemic confidence.

METHODS

Items were developed from interviews with six type 1 diabetes (T1D) adults, six insulin-using type 2 diabetes (T2D) adults, and seven diabetes healthcare professionals, resulting in nine self-report items. Separate exploratory factor analyses (EFAs) were conducted with T1D adults (N = 326), with T2D adults using both basal and prandial insulins (T2D-BP, N = 145) and with T2D adults using only basal insulin (T2D-BO, N = 82). Construct validity for the HCS was established with overall well-being (World Health Organization-5), diabetes distress (Diabetes Distress Scale), global anxiety (Generalized Anxiety Disorder), hypoglycemic fear (Hypoglycemic Fear Survey-II), and glycemic control (self-reported A1C). Hierarchical regression analyses examined the unique contribution of HCS scores, independent of hypoglycemic fear, on key psychosocial constructs and A1C.

RESULTS

EFAs of the nine HCS items yielded a single factor solution for each of the three subject samples, accounting for 50.8%, 65.1%, and 73.7% of the variance for the T1D, T2D-BP, and T2D-BO groups, respectively. Construct validity was established by significant correlations with criterion variables. The HCS was associated with well-being and diabetes distress in the T1D (in both cases, P < 0.001) and T2D-BP groups (in both cases, P < .05) and for self-reported A1C in the T2D-BP group (P < .05) independent of hypoglycemic fear.

CONCLUSIONS

Hypoglycemic confidence is a unique dimension of patient experience, different from hypoglycemic fear, and is deserving of further study. The HCS is a reliable valid measure of hypoglycemic confidence for adults with T1D and insulin-using T2D.

摘要

背景

虽然旨在了解糖尿病患者对低血糖的担忧的研究主要集中在对恐惧和焦虑的调查上,但最近的证据表明,存在一个潜在的重要且概念上不同的元素——低血糖信心。为了研究这一方面,我们开发了低血糖信心量表(HCS);在此,我们描述了 HCS 的构建和验证,并研究了关键患者因素与低血糖信心的关联。

方法

从六名 1 型糖尿病(T1D)成人、六名使用胰岛素的 2 型糖尿病(T2D)成人和七名糖尿病医疗保健专业人员的访谈中开发了项目,得出了 9 个自我报告项目。分别对 T1D 成人(N=326)、使用基础和餐前胰岛素的 T2D 成人(T2D-BP,N=145)和仅使用基础胰岛素的 T2D 成人(T2D-BO,N=82)进行了探索性因素分析(EFA)。使用总体幸福感(世界卫生组织-5)、糖尿病困扰(糖尿病困扰量表)、总体焦虑(广泛性焦虑障碍)、低血糖恐惧(低血糖恐惧调查-II)和血糖控制(自我报告的 A1C)来确定 HCS 的结构效度。分层回归分析检查了 HCS 分数在低血糖恐惧之外对关键心理社会结构和 A1C 的独特贡献。

结果

9 项 HCS 项目的 EFA 为三个样本组中的每一个产生了单一因素解决方案,分别占 T1D、T2D-BP 和 T2D-BO 组的 50.8%、65.1%和 73.7%的方差。通过与标准变量的显著相关性建立了结构效度。HCS 与 T1D(在两种情况下,P<0.001)和 T2D-BP 组(在两种情况下,P<0.05)的幸福感和糖尿病困扰以及 T2D-BP 组的自我报告 A1C(P<0.05)相关,而与低血糖恐惧无关。

结论

低血糖信心是患者体验的一个独特维度,与低血糖恐惧不同,值得进一步研究。HCS 是一种可靠有效的成人 1 型和使用胰岛素的 2 型糖尿病患者低血糖信心的测量工具。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验